Iatrogenic ischemic strokes: other causes

doi:10.1017/CBO9781139775397.012

Moller, T R, Brorsson, B, Ceberg, J, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol. 2003; 42:387–410.

Slotman, B, Faivre-Finn, C, Kramer, G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007; 357:664–72.

Morris, B, Partap, S, Yeom, K, et al. Cerebrovascular disease in childhood cancer survivors: A children’s oncology group report. Neurology. 2009; 73:1906–13.

Bowers, D C, Liu, Y, Leisenring, W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: A report from the childhood cancer survivor study. J Clin Oncol. 2006; 24:5277–82.

Campen, C J, Kranick, S M, Kasner, S E, et al. Cranial irradiation increases risk of stroke in pediatric brain tumor survivors. Stroke. 2012; 43:3035–40.

Grisold, W, Oberndorfer, S, Struhal, W. Stroke and cancer: A review. Acta Neurol Scand. 2009; 119:1–16.

Labauge, P, Laberge, S, Brunereau, L, Levy, C, Tournier-Lasserve, E. Hereditary cerebral cavernous angiomas: Clinical and genetic features in 57 French families. Societe Francaise de Neurochirurgie. Lancet. 1998; 352:1892–7.

Gunel, M, Awad, I A, Finberg, K, et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996; 334:946–51.

Laberge-le Couteulx, S, Jung, H H, Labauge, P, et al. Truncating mutations in ccm1, encoding krit1, cause hereditary cavernous angiomas. Nat Genet. 1999; 23:189–93.

Bergametti, F, Denier, C, Labauge, P, et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet. 2005; 76:42–51.

Nimjee, S M, Powers, C J, Bulsara, K R. Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy. Neurosurg Focus. 2006; 21:e4.

Lew, S M, Morgan, J N, Psaty, E, et al. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg. 2006; 104:103–7.

Al-Shahi Salman, R, Hall, J M, Horne, M A, et al. Untreated clinical course of cerebral cavernous malformations: A prospective, population-based cohort study. Lancet Neurol. 2012; 11:217–24.

Kivelev, J, Niemela, M, Hernesniemi, J. Treatment strategies in cavernomas of the brain and spine. J Clin Neurosci. 2012; 19:491–7.

Niranjan, A, Lunsford, L D. Stereotactic radiosurgery guidelines for the management of patients with intracranial cavernous malformations. Prog Neurol Surg. 2013; 27:166–75.

Schneble, H M, Soumare, A, Herve, D, et al. Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke. 2012; 43:3196–9.

de Weerd, M, Greving, J P, Hedblad, B, et al. Prevalence of asymptomatic carotid artery stenosis in the general population: An individual participant data meta-analysis. Stroke. 2010; 41:1294–7.

Compter, A, van der Worp, H B, Algra, A, Kappelle, L J. Second manifestations of AdSG. Prevalence and prognosis of asymptomatic vertebral artery origin stenosis in patients with clinically manifest arterial disease. Stroke. 2011; 42:2795–800.

Marquardt, L, Kuker, W, Chandratheva, A, Geraghty, O, Rothwell, P M. Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: Prospective population-based study. Brain. 2009; 132:982–8.

Feldmann, E, Daneault, N, Kwan, E, et al. Chinese-White differences in the distribution of occlusive cerebrovascular disease. Neurology. 1990; 40:1541–5.

Plummer, C, Henderson, R D, O’Sullivan, J D, Read, S J. Ischemic stroke and transient ischemic attack after head and neck radiotherapy: A review. Stroke. 2011; 42:2410–18.

Scott, A S, Parr, L A, Johnstone, P A. Risk of cerebrovascular events after neck and supraclavicular radiotherapy: A systematic review. Radiother Oncol. 2009; 90:163–5.

Jagsi, R, Griffith, K A, Koelling, T, Roberts, R, Pierce, L J. Stroke rates and risk factors in patients treated with radiation therapy for early-stage breast cancer. J Clin Oncol. 2006; 24:2779–85.

Nilsson, G, Holmberg, L, Garmo, H, Terent, A, Blomqvist, C. Increased incidence of stroke in women with breast cancer. Eur J Cancer. 2005; 41:423–9.

Nilsson, G, Holmberg, L, Garmo, H, Terent, A, Blomqvist, C. Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke. Br J Cancer. 2009; 100:811–16.

Hooning, M J, Dorresteijn, L D, Aleman, B M, et al. Decreased risk of stroke among 10-year survivors of breast cancer. J Clin Oncol. 2006; 24:5388–94.

Zou, W X, Leung, T W, Yu, S C, et al. Angiographic features, collaterals, and infarct topography of symptomatic occlusive radiation vasculopathy: A case-referent study. Stroke. 2013; 44:401–6.

Murros, K E, Toole, J F. The effect of radiation on carotid arteries. A review article. Arch Neurol. 1989; 46:449–55.

O’Connor, M M, Mayberg, M R. Effects of radiation on cerebral vasculature: A review. Neurosurgery. 2000; 46:138–49.

Fokkema, M, den Hartog, A G, Bots, M L, et al. Stenting versus surgery in patients with carotid stenosis after previous cervical radiation therapy: Systematic review and meta-analysis. Stroke. 2012; 43:793–801.

Abbott, A L. Carotid surgery or stenting following neck irradiation: Time to address the assumptions. Eur J Vasc Endovasc Surg. 2012; 43:8–9.

McDonald, M W, Moore, M G, Johnstone, P A. Risk of carotid blowout after reirradiation of the head and neck: A systematic review. Int J Radiat Oncol Biol Phys. 2012; 82:1083–9.

Haas, R A, Ahn, S H. Interventional management of head and neck emergencies: Carotid blowout. Semin Intervent Radiol. 2013; 30:245–8.

Bowers, D C, Mulne, A F, Reisch, J S, et al. Nonperioperative strokes in children with central nervous system tumors. Cancer. 2002; 94:1094–101.

Grill, J, Couanet, D, Cappelli, C, et al. Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol. 1999; 45:393–6.

Erridge, S C, Conkey, D S, Stockton, D, et al. Radiotherapy for pituitary adenomas: Long-term efficacy and toxicity. Radiother Oncol. 2009; 93:597–601.

Flickinger, J C, Nelson, P B, Taylor, F H, Robinson, A. Incidence of cerebral infarction after radiotherapy for pituitary adenoma. Cancer. 1989; 63:2404–8.

Bowen, J, Paulsen, C A. Stroke after pituitary irradiation. Stroke. 1992; 23:908–11.

Brada, M, Burchell, L, Ashley, S, Traish, D. The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys. 1999; 45:693–8.

Bailey, E L, Smith, C, Sudlow, C L, Wardlaw, J M. Pathology of lacunar ischemic stroke in humans: A systematic review. Brain Pathol. 2012; 22:583–91.

Millikan, C, Futrell, N. The fallacy of the lacune hypothesis. Stroke. 1990; 21:1251–7.

Futrell, N. Lacunar infarction: Embolism is the key. Stroke. 2004; 35:1778–9.

Futrell, N, Millikan, C, Watson, B D, Dietrich, W D, Ginsberg, M D. Embolic stroke from a carotid arterial source in the rat: Pathology and clinical implications. Neurology. 1989; 39:1050–6.

Norrving, B. Lacunar infarcts: No black holes in the brain are benign. Pract Neurol. 2008; 8:222–8.

Patel, B, Markus, H S. Magnetic resonance imaging in cerebral small vessel disease and its use as a surrogate disease marker. Int J Stroke. 2011; 6:47–59.

Kwee, R M, Kwee, T C. Virchow–Robin spaces at MR imaging. Radiographics. 2007; 27:1071–86.

Gouw, A A, Seewann, A, van der Flier, W M, et al. Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry. 2011; 82:126–35.

Atwood, L D, Wolf, P A, Heard-Costa, N L, et al. Genetic variation in white matter hyperintensity volume in the Framingham study. Stroke. 2004; 35:1609–13.

Fornage, M, Debette, S, Bis, J C, et al. Genome-wide association studies of cerebral white matter lesion burden: The charge consortium. Ann Neurol. 2011; 69:928–39.

Debette, S, Markus, H S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: Systematic review and meta-analysis. BMJ. 2010; 341:c3666.

Ebi, J, Sato, H, Nakajima, M, Shishido, F. Incidence of leukoencephalopathy after whole-brain radiation therapy for brain metastases. Int J Radiat Oncol Biol Phys. 2012.

DeAngelis, L M, Delattre, J Y, Posner, J B. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989; 39:789–96.

Schrag, M, McAuley, G, Pomakian, J, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: A postmortem MRI study. Acta Neuropathol. 2010; 119:291–302.

Fazekas, F, Kleinert, R, Roob, G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: Evidence of microangiopathy-related microbleeds. Am J Neuroradiol. 1999; 20:637–42.

Fisher, M, French, S, Ji, P, Kim, R C. Cerebral microbleeds in the elderly: A pathological analysis. Stroke. 2010; 41:2782–5.

Schrag, M, McAuley, G, Pomakian, J, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: A postmortem MRI study. Acta Neuropathol. 2009.

Greenberg, S M, Vernooij, M W, Cordonnier, C, et al. Cerebral microbleeds: A guide to detection and interpretation. Lancet Neurol. 2009; 8:165–74.

Roob, G, Schmidt, R, Kapeller, P, et al. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology. 1999; 52:991–4.

Vernooij, M W, van der Lugt, A, Ikram, M A, et al. Prevalence and risk factors of cerebral microbleeds: The Rotterdam scan study. Neurology. 2008; 70:1208–14.

Benavente, O R, Hart, R G, McClure, L A, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012; 367:817–25.

Brisman, J L, Song, J K, Newell, D W. Cerebral aneurysms. N Engl J Med. 2006; 355:928–39.

van Gijn, J, Kerr, R S, Rinkel, G J. Subarachnoid haemorrhage. Lancet. 2007; 369:306–18.

Vernooij, M W, Ikram, M A, Tanghe, H L, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007; 357:1821–8.

Feigin, V L, Rinkel, G J, Lawes, C M, et al. Risk factors for subarachnoid hemorrhage: An updated systematic review of epidemiological studies. Stroke. 2005; 36:2773–80.

Wiebers, D O, Whisnant, J P, Huston, J 3rd, et al. Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003; 362:103–10.

Lau, W Y, Chow, C K. Radiation-induced petrous internal carotid artery aneurysm. Ann Otol Rhinol Laryngol. 2005; 114:939–40.

Sciubba, D M, Gallia, G L, Recinos, P, Garonzik, I M, Clatterbuck, R E. Intracranial aneurysm following radiation therapy during childhood for a brain tumor. Case report and review of the literature. J Neurosurg. 2006; 105:134–9.

Kuroda, S, Houkin, K. Moyamoya disease: Current concepts and future perspectives. Lancet Neurol. 2008; 7:1056–66.

Liu, W, Morito, D, Takashima, S, et al. Identification of rnf213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011; 6:e22542.

Kamada, F, Aoki, Y, Narisawa, A, et al. A genome-wide association study identifies rnf213 as the first moyamoya disease gene. J Hum Genet. 2011; 56:34–40.

Kestle, J R, Hoffman, H J, Mock, A R. Moyamoya phenomenon after radiation for optic glioma. J Neurosurg. 1993; 79:32–5.

Ullrich, N J, Robertson, R, Kinnamon, D D, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007; 68:932–8.

Pandey, P, Steinberg, G K. Neurosurgical advances in the treatment of moyamoya disease. Stroke. 2011; 42:3304–10.

Shuper, A, Packer, R J, Vezina, L G, Nicholson, H S, Lafond, D. ‘Complicated migraine-like episodes’ in children following cranial irradiation and chemotherapy. Neurology. 1995; 45:1837–40.

Black, D F, Morris, J M, Lindell, E P, et al. Stroke-like migraine attacks after radiation therapy (SMART) syndrome is not always completely reversible: A case series. Am J Neuroradiol. 2013; 34:2298–303.

Tomek, M, Bhavsar, S V, Patry, D, Hanson, A. The syndrome of stroke-like migraine attacks after radiation therapy associated with prolonged unresponsiveness in an adult patient. Neurologist. 2015; 19:49–52.

Armstrong, A E, Gillan, E, DiMario, F J Jr. SMART syndrome (stroke-like migraine attacks after radiation therapy) in adult and pediatric patients. J Child Neurol. 2014; 29:336–41.

Farid, K, Meissner, W G, Samier-Foubert, A, et al. Normal cerebrovascular reactivity in stroke-like migraine attacks after radiation therapy syndrome. Clin Nucl Med. 2010; 35:583–5.

Smith, G L, Smith, B D, Buchholz, T A, et al. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. J Clin Oncol. 2008; 26:5119–25.

Haynes, J C, Machtay, M, Weber, R S, et al. Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation. Laryngoscope. 2002; 112:1883–7.

Dorresteijn, L D, Kappelle, A C, Boogerd, W, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002; 20:282–8.

Elerding, S C, Fernandez, R N, Grotta, J C, et al. Carotid artery disease following external cervical irradiation. Ann Surg. 1981; 194:609–15.

De Bruin, M L, Dorresteijn, L D, van’t Veer, M B, et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst. 2009; 101:928–37.

Moser, E C, Noordijk, E M, van Leeuwen, F E, et al. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood. 2006; 107:2912–19.

Schievink, W I. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med. 2001; 344:898–906.

Ferro, J M, Massaro, A R, Mas, J L. Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol. 2010; 9:1085–96.

Longoni, M, Grond-Ginsbach, C, Grau, A J, et al. The ICAM-1 E469 K gene polymorphism is a risk factor for spontaneous cervical artery dissection. Neurology. 2006; 66:1273–5.

Pezzini, A, Del Zotto, E, Archetti, S, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002; 33:664–9.

Gallai, V, Caso, V, Paciaroni, M, et al. Mild hyperhomocyst(e)inemia: a possible risk factor for cervical artery dissection. Stroke. 2001; 32:714–18.

Konrad, C, Muller, G A, Langer, C, et al. Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol. 2004; 251:1242–8.

Silbert, P L, Mokri, B, Schievink, W I. Headache and neck pain in spontaneous internal carotid and vertebral artery dissections. Neurology. 1995; 45:1517–22.

Lee, V H, Brown, R D Jr., Mandrekar, J N, Mokri, B. Incidence and outcome of cervical artery dissection: a population-based study. Neurology. 2006; 67:1809–12.

Mokri, B, Silbert, P L, Schievink, W I, Piepgras, D G. Cranial nerve palsy in spontaneous dissection of the extracranial internal carotid artery. Neurology. 1996;46:356–9.

Arnold, M, Cumurciuc, R, Stapf, C, et al. Pain as the only symptom of cervical artery dissection. J Neurol Neurosurg Psychiatry. 2006; 77:1021–4.

Biousse, V, D’Anglejan-Chatillon, J, Touboul, P J, Amarenco, P, Bousser, M G. Time course of symptoms in extracranial carotid artery dissections. A series of 80 patients. Stroke. 1995; 26:235–9.

Saeed, A B, Shuaib, A, Al-Sulaiti, G, Emery, D. Vertebral artery dissection: Warning symptoms, clinical features and prognosis in 26 patients. Can J Neurol Sci. 2000; 27:292–6.

Hurwitz, E L, Aker, P D, Adams, A H, Meeker, W C, Shekelle, P G. Manipulation and mobilization of the cervical spine. A systematic review of the literature. Spine. 1996; 21:1746–60.

Haldeman, S, Carey, P, Townsend, M, Papadopoulos, C. Arterial dissections following cervical manipulation: the chiropractic experience. CMAJ. 2001; 165:905–6.

Thornton, R V. Malpractice: death resulting from chiropractic treatment of headache (medicolegal abstract). JAMA. 1934; 103:1260.

Haneline, M T, Croft, A C, Frishberg, B M. Association of internal carotid artery dissection and chiropractic manipulation. Neurologist. 2003; 9:35–44.

Dziewas, R, Konrad, C, Drager, B, et al. Cervical artery dissection: Clinical features, risk factors, therapy and outcome in 126 patients. J Neurol. 2003; 250:1179–84.

Lee, K P, Carlini, W G, McCormick, G F, Albers, G W. Neurologic complications following chiropractic manipulation: a survey of California neurologists. Neurology. 1995; 45:1213–15.

Norris, J W, Beletsky, V, Nadareishvili, Z G. Sudden neck movement and cervical artery dissection. The Canadian Stroke Consortium. CMAJ. 2000; 163:38–40.

Dabbs, V, Lauretti, W J. A risk assessment of cervical manipulation vs. NSAIDs for the treatment of neck pain. J Manipulative Physiol Ther. 1995; 18:530–6.

Haneline, M T, Lewkovich, G. Identification of internal carotid artery dissection in chiropractic practice. J Can Chiropr Assoc. 2004; 48:206–10.

Schievink, W I, Mokri, B, Whisnant, J P. Internal carotid artery dissection in a community. Rochester, Minnesota, 1987–1992. Stroke. 1993; 24:1678–80.

Giroud, M, Fayolle, H, Andre, N, et al. Incidence of internal carotid artery dissection in the community of Dijon. J Neurol Neurosurg Psychiatry. 1994; 57:1443.

Assendelft, W J, Bouter, L M, Knipschild, P G. Complications of spinal manipulation: A comprehensive review of the literature. J Fam Pract. 1996; 42:475–80.

Showalter, W, Esekogwu, V, Newton, K I, Henderson, S O. Vertebral artery dissection. Acad Emerg Med. 1997; 4:991–5.

Dvorak, J, Orelli, F V. How dangerous is manipulation to the cervical spine? Man Med. 1985; 2:1–4.

Klougart, N, Leboeuf-Yde, C, Rasmussen, L R. Safety in chiropractic practice, Part I; The occurrence of cerebrovascular accidents after manipulation to the neck in Denmark from 1978–1988. J Manipulative Physiol Ther. 1996; 19:371–7.

Haldeman, S, Carey, P, Townsend, M, Papadopoulos, C. Clinical perceptions of the risk of vertebral artery dissection after cervical manipulation: the effect of referral bias. Spine J. 2002; 2:334–42.

Haldeman, S, Kohlbeck, F J, McGregor, M. Unpredictability of cerebrovascular ischemia associated with cervical spine manipulation therapy: a review of sixty-four cases after cervical spine manipulation. Spine. 2002; 27:49–55.

Reuter, U, Hamling, M, Kavuk, I, Einhaupl, K M, Schielke, E. Vertebral artery dissections after chiropractic neck manipulation in Germany over three years. J Neurol. 2006; 253:724–30.

Haldeman, S, Kohlbeck, F J, McGregor, M. Stroke, cerebral artery dissection, and cervical spine manipulation therapy. J Neurol. 2002; 249:1098–104.

Hufnagel, A, Hammers, A, Schonle, P W, Bohm, K D, Leonhardt, G. Stroke following chiropractic manipulation of the cervical spine. J Neurol. 1999; 246:683–8.

Rothwell, D M, Bondy, S J, Williams, J I. Chiropractic manipulation and stroke: a population-based case-control study. Stroke. 2001; 32:1054–60.

Whedon, J M, Song, Y, Mackenzie, T A, et al. Risk of stroke after chiropractic spinal manipulation in Medicare B beneficiaries aged 66 to 99 years with neck pain. J Manipulative Physiol Ther. 2015; 38:93–101.

Smith, W S, Johnston, S C, Skalabrin, E J, et al. Spinal manipulative therapy is an independent risk factor for vertebral artery dissection. Neurology. 2003; 60:1424–8.

Dittrich, R, Rohsbach, D, Heidbreder, A, et al. Mild mechanical traumas are possible risk factors for cervical artery dissection. Cerebrovasc Dis. 2007; 23:275–81.

Wynd, S, Westaway, M, Vohra, S, Kawchuk, G. The quality of reports on cervical arterial dissection following cervical spinal manipulation. PLoS One. 2013; 8:e59170.

Haynes, M J, Vincent, K, Fischhoff, C, et al. Assessing the risk of stroke from neck manipulation: A systematic review. Int J Clin Pract. 2012; 66:940–7.

Cassidy, J D, Boyle, E, Cote, P, et al. Risk of vertebrobasilar stroke and chiropractic care: results of a population-based case-control and case-crossover study. J Manipulative Physiol Ther. 2009; 32:S201–208.

Guillon, B, Berthet, K, Benslamia, L, et al. Infection and the risk of spontaneous cervical artery dissection: a case-control study. Stroke. 2003; 34:e79–81.

Cagnie, B, Barbaix, E, Vinck, E, D’Herde, K, Cambier, D. Atherosclerosis in the vertebral artery: an intrinsic risk factor in the use of spinal manipulation? Surg Radiol Anat. 2006; 28:129–34.

Pezzini, A, Del Zotto, E, Padovani, A. Hyperhomocysteinemia: a potential risk factor for cervical artery dissection following chiropractic manipulation of the cervical spine. J Neurol. 2002; 249:1401–3.

Frisoni, G B, Anzola, G P. Neck manipulation and stroke. Neurology. 1990; 40:1910.

Scott, A A, Welsh, R P. Fat embolism: A rational approach to treatment. Can Med Assoc J. 1973; 109(9):867–71.

Talbot, M, Schemitsch, E H. Fat embolism syndrome: History, definition, epidemiology. Injury. 2006; 37(Suppl 4):S3–S7.

Klingele, K, Bhalla, T, Sawardekar, A, Tobias, J D. Postoperative hypoxemia due to fat embolism. Saudi J Anaesth. 2011; 5(3):332–4.

Weisz, G M, Barzilai, A. Fat embolism: Physiopathology, diagnosis with management. Arch Orthop Unfall-Chir. 1975; 82(3):217–23.

Habashi, N M, Andrews, P L, Scalea, T M. Therapeutic aspects of fat embolism syndrome. Injury. 2006; 37(Suppl 4):S68–S73.

Fulde, G W, Harrison, P. Fat embolism: A review. Arch Emerg Med. 1991; 8(4):233–9.

Christie, J, Robinson, C M, Pell, A C, McBirnie, J, Burnett, R. Transcardiac echocardiography during invasive intramedullary procedures. J Bone Joint Surg Br. 1995; 77(3):450–5.

Gurd, A R, Wilson, R I. The fat embolism syndrome. J Bone Joint Surg Br. 1974; 56B(3):408–16.

Allardyce, D B, Meek, R N, Woodruff, B, Cassim, M M, Ellis, D. Increasing our knowledge of the pathogenesis of fat embolism: A prospective study of 43 patients with fractured femoral shafts. J Trauma. 1974; 14(11):955–62.

Bulger, E M, Smith, D G, Maier, R V, Jurkovich, G J. Fat embolism syndrome. A 10-year review. Arch Surg. 1997; 132(4):435–9.

Fabian, T C, Hoots, A V, Stanford, D S, Patterson, C R, Mangiante, E C. Fat embolism syndrome: Prospective evaluation in 92 fracture patients. Crit Care Med. 1990; 18(1):42–6.

Robert, J H, Hoffmeyer, P, Broquet, P E, Cerutti, P, Vasey, H. Fat embolism syndrome. Orthop Rev. 1993; 22(5):567–71.

Pinney, S J, Keating, J F, Meek, R N. Fat embolism syndrome in isolated femoral fractures: Does timing of nailing influence incidence? Injury. 1998; 29(2):131–3.

Campo-López, C, Flors-Villaverde, P, Calabuig-Alborch, J R. Fat embolism syndrome after bone fractures. Rev Clin Esp. 2012; 212(10):482–7.

Tsai, I T, Hsu, C J, Chen, Y H, et al. Fat embolism syndrome in long bone fracture–clinical experience in a tertiary referral center in Taiwan. J Chin Med Assoc. 2010; 73(8):407–10.

Talucci, R C, Manning, J, Lampard, S, Bach, A, Carrico, C J. Early intramedullary nailing of femoral shaft fractures: A cause of fat embolism syndrome. Am J Surg. 1983; 146(1):107–11.

Bone, L B, Johnson, K D, Weigelt, J, Scheinberg, R. Early versus delayed stabilization of femoral fractures. A prospective randomized study. J Bone Joint Surg Am. 1989; 71(3):336–40.

Findlay, J M, DeMajo, W. Cerebral fat embolism. Can Med Assoc J. 1984; 131(7):755–7.

Taviloglu, K, Yanar, H. Fat embolism syndrome. Surg Today. 2007; 37(1):5–8.

Duja, C M, Berna, C, Kremer, S, et al. Confusion after spine injury: Cerebral fat embolism after traumatic rupture of a Tarlov cyst: Case report. BMC Emerg Med. 2010; 10:18.

Powers, K A, Talbot, L A. Case report: Fat embolism syndrome after femur fracture with intramedullary nailing. Am J Crit Care. 2011; 20:264–6.

Thienpont, E, Kaddar, S, Morrison, S. Paradoxical fat embolism after uncemented total hip arthroplasty: A case report. Acta Orthop Belg. 2007; 73(3):418–20.

Sasano, N, Ishida, S, Tetsu, S, et al. Cerebral fat embolism diagnosed by magnetic resonance imaging at one, eight, and 50 days after hip arthroplasty: A case report. Can J Anaesth. 2004; 51(9):875–987.

Rodriguez-Merchan, E C, Comin-Gomez, J A, Martinez-Chacon, J L. Cerebral embolism during revision arthroplasty of the hip. Acta Orthop Belg. 1995; 61(4):319–22.

Ammon, J T, Khalily, C, Lester, D K. Fatal cerebral emboli in the absence of a cardiac arterial-venous shunt: Case report. J Arthroplasty. 2007; 22(3):477–9.

Chang, R N, Kim, J H, Lee, H, et al. Cerebral fat embolism after bilateral total knee replacement arthroplasty: A case report. Korean J Anesthesiol. 2010; 59 Suppl:S207–S210.

Jenkins, K, Chung, F, Wennberg, R, Etchells, E E, Davey, R. Fat embolism syndrome and elective knee arthroplasty. Can J Anaesth. 2002; 49(1):19–24.

Lee, S C, Yoon, J Y, Nam, C H, et al. Cerebral fat embolism syndrome after simultaneous bilateral total knee arthroplasty: A case series. J Arthroplasty. 2012; 27(3):409–14.

Ghatak, N R, Sinnenberg, R J, deBlois, G G. Cerebral fat embolism following cardiac surgery. Stroke. 1983; 14(4):619–21.

Wang, H D, Zheng, J H, Deng, C L, Liu, Q Y, Yang, S L. Fat embolism syndromes following liposuction. Aesthetic Plast Surg. 2008; 32(5):731–6.

Laub, D R Jr. Fat embolism syndrome after liposuction: A case report and review of the literature. Ann Plast Surg. 1990; 25(1):48–52.

Richards, R R. Fat embolism syndrome. Can J Surg. 1997; 40(5):334–9.

Mossa-Basha, M, Izbudak, I, Gurda, G T, Aygun, N. Cerebral fat embolism syndrome in sickle cell anaemia/β-thalassemia: Importance of susceptibility-weighted MRI. Clin Radiol. 2012; 67(10):1023–6.

Barson, A J, Chistwick, M L, Doig, C M. Fat embolism in infancy after intravenous fat infusions. Arch Dis Child. 1978; 53(3):218–23.

Bhalla, A, Sachdev, A, Lehl, S S, Singh, R, D’Cruz, S. Cerebral fat embolism as a rare possible complication of traumatic pancreatitis. JOP. 2003; 4(4):155–7.

Guardia, S N, Bilbao, J M, Murray, D, Warren, R E, Sweet, J. Fat embolism in acute pancreatitis. Arch Pathol Lab Med. 1989; 113:503–6.

Dang, N C, Johnson, C, Eslami-Farsani, M, Haywood, L J. Bone marrow embolism in sickle cell disease: A review. Am J Hematol. 2005; 79(1):61–7.

Desselle, B C, O’Brien, T, Bugnitz, M, et al. Fatal fat embolism in a patient with sickle-beta+ thalassemia. Pediatr Hematol Oncol. 1995; 12(2):159–62.

ten Duis, H J. The fat embolism syndrome. Injury. 1997; 28(2):77–85.

Cox, G, Tzioupis, C, Calori, G M, et al. Cerebral fat emboli: A trigger of post-operative delirium. Injury. 2011; 42(S4):S6–S10.

Etchells, E E, Wong, D T, Davidson, G, Houston, P L. Fatal cerebral fat embolism associated with a patent foramen ovale. Chest. 1993; 104(3):962–3.

Gossling, H R, Pellegrini, V D Jr. Fat embolism syndrome: A review of the pathophysiology and physiological basis of treatment. Clin Orthop Relat Res. 1982; 165:68–82.

Butteriss, D J, Mahad, D, Soh, C, et al. Reversible cytotoxic cerebral edema in cerebral fat embolism. Am J Neuroradiol. 2006; 27(3):620–3.

Parisi, D M, Koval, K, Egol, K. Fat embolism syndrome. Am J Orthop. 2002; 31(9):507–12.

Adams, C B. The retinal manifestations of fat embolism. Injury. 1971; 2(3):221–4.

Murray, D G, Racz, G B. Fat embolism syndrome (respiratory insufficiency syndrome). A rationale for treatment. J Bone Joint Surg. 1974; 56(7):1338–49.

Koch, S, Forteza, A, Lavernia, C, et al. Cerebral fat microembolism and cognitive decline after hip and knee replacement. Stroke. 2007; 38(3):1079–81.

Sulek, C A, Davies, L K, Enneking, F K, Gearen, P A, Lobato, E B. Cerebral microembolism diagnosed by transcranial Doppler during total knee arthroplasty: Correlation with transesophageal echocardiography. Anesthesiology. 1999; 91(3):672–6.

Van Besouw, J P, Hinds, C J. Fat embolism syndrome. Br J Hosp Med. 1989; 42(4):304–6.

Finlay, M E, Benson, M D. Case report: Magnetic resonance imaging in cerebral fat embolism. Clin Radiol. 1996; 51(6):445–6.

Gombar, S, Dey, N, Deva, C. Pupillary signs in fat embolism syndrome. Acta Anaesthesiol Scand. 2005; 49(5):723.

Manousakis, G, Han, D Y, Backonja, M. Cognitive outcome of cerebral fat embolism. J Stroke Cerebrovasc Dis. 2012; 21(8):906–8.

Thomas, J E, Ayyar, D R. Systemic fat embolism. A diagnostic profile in 24 patients. Arch Neurol. 1972; 26(6):517–23.

Bardana, D, Rudan, J, Cervenko, F, Smith, R. Fat embolism syndrome in a patient demonstrating only neurologic symptoms. Can J Surg. 1998; 41(5):398–402.

Jacobson, D M, Terrence, C F, Reinmuth, O M. The neurologic manifestations of fat embolism. Neurology. 1986; 36:847–51.

Metting, Z, Rödiger, L A, Regtien, J G, van der Naalt, J. Delayed coma in head injury: consider cerebral fat embolism. Clin Neurol Neurosurg. 2009; 111(7):597–600.

Johnson, M J, Lucas, G L. Fat embolism syndrome. Orthopedics. 1996; 19(1):41–8.

Oh, W H, Mital, M A. Fat embolism: Current concepts of pathogenesis, diagnosis, and treatment. Orthop Clin North Am. 1978; 9(3):769–79.

Gurd, A R. Fat embolism: An aid to diagnosis. J Bone Joint Surg Br. 1970; 52(4):732–7.

Vedrinne, J M, Guillaume, C, Gagnieu, M C, et al. Bronchoalveolar lavage in trauma patients for diagnosis of fat embolism syndrome. Chest. 1992; 102(5):1323–7.

Weisz, G M, Rang, M, Salter, R B. Posttraumatic fat embolism in children: Review of the literature and of experience in the Hospital for Sick Children, Toronto. J Trauma. 1973; 13(6):529–34.

Schonfeld, S A, Ploysongsang, Y, DiLisio, R, et al. Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med. 1983; 99(4):438–43.

Lindeque, B G, Schoeman, H S, Dommisse, G F, Boeyens, M C, Vlok, A L. Fat embolism and the fat embolism syndrome. A double-blind therapeutic study. J Bone Joint Surg Br. 1987; 69(1):128–31.

Mellor, A, Soni, N. Fat embolism. Anaesthesia. 2001; 56(2):145–54.

Shaikh, N. Emergency management of fat embolism syndrome. J Emerg Trauma Shock. 2009; 2(1):29–33.

Costa, A N, Mendes, D M, Toufen, C, et al. Adult respiratory distress syndrome due to fat embolism in the postoperative period following liposuction and fat grafting. J Bras Pneumol. 2008; 34(8):622–5.

Chastre, J, Fagon, J Y, Soler, P, et al. Bronchoalveolar lavage for rapid diagnosis of the fat embolism syndrome in trauma patients. Ann Intern Med. 1990; 113(8):583–8.

Forteza, A M, Koch, S, Romano, J G, et al. Transcranial Doppler detection of fat emboli. Stroke. 1999; 30(12):2687–91.

Belvis, R, Leta, R G, Marti-Fabregas, J, et al. Almost perfect concordance between simultaneous transcranial Doppler and transesophageal echocardiography in the quantification of right-to-left shunts. J Neuroimaging. 2006; 16(2):133–8.

Forteza, A M, Koch, S, Campo-Bustillo, I, et al. Transcranial Doppler detection of cerebral fat emboli and relation to paradoxical embolism: A pilot study. Circulation. 2011; 123(18):1947–52.

Gupta, B, Kaur, M, d’Souza, N, et al. Cerebral fat embolism: A diagnostic challenge. Saudi J Anaesth. 2011; 5(3):348–52.

Salazar, J A, Romero, F, Padilla, F, Arboleda, J A, Fernández, O. Neurological manifestations of fat embolism syndrome. Neurologia. 1995; 10(2):65–9.

Sakamoto, T, Sawada, Y, Yukioka, T, et al. Computed tomography for diagnosis and assessment of cerebral fat embolism. Neuroradiology. 1983; 24(5):283–5.

Beers, G J, Nichols, G R, Willing, S J. CT demonstration of fat-embolism-associated hemorrhage in the anterior commissure. Am J Neuroradiol. 1988; 9(1):212–13.

Stoeger, A, Daniaux, M, Felber, S, et al. MRI findings in cerebral fat embolism. Eur Radiol. 1998; 8(9):1590–93.

Marshall, G B, Heale, V R, Herx, L, et al. Magnetic resonance diffusion weighted imaging in cerebral fat embolism. Can J Neurol Sci. 2004; 31(3):417–21.

Ryu, C W, Lee, D H, Kim, T K, et al. Cerebral fat embolism: Diffusion-weighted magnetic resonance imaging findings. Acta Radiol. 2005; 46(5):528–33.

Aravapalli, A, Fox, J, Lazaridis, C. Cerebral fat embolism and the ‘starfield’ pattern: A case report. Cases J. 2009; 2:212–14.

Pfeffer, G, Heran, M K. Restricted diffusion and poor clinical outcome in cerebral fat embolism syndrome. Can J Neurol Sci. 2010; 37(1):128–30.

Buskens, C J, Gratama, J W, Hogervorst, M, et al. Encephalopathy and MRI abnormalities in fat embolism syndrome: A case report. Med Sci Monit. 2008; 14(11):CS125–129.

Citerio, G, Bianchini, E, Beretta, L. Magnetic resonance imaging of cerebral fat embolism: A case report. Intensive Care Med. 1995; 21(8):679–81.

Yoshida, A, Okada, Y, Nagata, Y, Hanaguri, K, Morio, M. Assessment of cerebral fat embolism by magnetic resonance imaging in the acute stage. J Trauma. 1996; 40(3):437–40.

Simon, A D, Ulmer, J L, Strottmann, J M. Contrast-enhanced MR imaging of cerebral fat embolism: Case report and review of the literature. Am J Neuroradiol. 2003; 24(1):97–101.

Lee, J. Gradient-echo MRI in defining the severity of cerebral fat embolism. J Clin Neurol. 2008; 4(4):164–6.

Evert, A Eriksson, E A, Sarah, E et al. Cerebral fat embolism without intracardiac shunt: A novel presentation. Emerg Trauma Shock. 2011; 4(2):309–12.

Stoltenberg, J J, Gustilo, R B. The use of methylprednisolone and hypertonic glucose in the prophylaxis of fat embolism syndrome. Clin Orthop Relat Res. 1979; 143:211–21.

Kallenbach, J, Lewis, M, Zaltzman, M, et al. Low-dose corticosteroid prophylaxis against fat embolism. J Trauma. 1987; 27(10):1173–6.

Bederman, S S, Bhandari, M, McKee, M D, Schemitsch, E H. Do corticosteroids reduce the risk of fat embolism syndrome in patients with long-bone fractures? A meta-analysis. Can J Surg. 2009; 52(5):386–93.

Johnson, K D, Cadambi, A, Seibert, G B. Incidence of adult respiratory distress syndrome in patients with multiple musculoskeletal injuries: Effect of early operative stabilization of fractures. J Trauma. 1985; 25(5):375–84.

White, T, Petrisor, B A, Bhandari, M. Prevention of fat embolism syndrome. Injury. 2006; 37(Suppl 4):S59–67.

Muth, C M, Shank, E S. Gas embolism. N Engl J Med. 2000; 342(7):476–82.

Shaikh, N, Ummunisa, F. Acute management of vascular air embolism. J Emerg Trauma Shock. 2009; 2(3):180–5.

Green, B T, Tendler, D A. Cerebral air embolism during upper endoscopy: Case report and review. Gastrointest Endosc. 2005; 61(4):620–3.

Bou-Assaly, W, Pernicano, P, Hoeffner, E. Systemic air embolism after transthoracic lung biopsy: A case report and review of literature. World J Radiol. 2010; 2(5):193–6.

Mirski, M A, Lele, A V, Fitzsimmons, L, Toung, T J. Diagnosis and treatment of vascular air embolism. Anesthesiology. 2007; 106(1):164–77.

Herron, D M, Vernon, J K, Gryska, P V, Reines, H D. Venous gas embolism during endoscopy. Surg Endosc. 1999; 13(3):276–9.

Kashuk, J L, Penn, I. Air embolism after central venous catheterization. Surg Gynecol Obstet. 1984; 159(3):249–52.

Leach, R M, Rees, P J, Wilmshurst, P. Hyperbaric oxygen therapy. BMJ. 1998; 317(7166):1140–3.

Standefer, M, Bay, J W, Trusso, R. The sitting position in neurosurgery: A retrospective analysis of 488 cases. Neurosurgery. 1984; 14(6):649–58.

Papadopoulos, G, Kuhly, P, Brock, M, et al. Venous and paradoxical air embolism in the sitting position. A prospective study with transoesophageal echocardiography. Acta Neurochir. 1994; 126(2–4):140–3.

Ngai, S H, Stinchfield, F E, Triner, L. Air embolism during total hip arthroplasties. Anesthesiology. 1974; 40(4):405–7.

Spiess, B D, Sloan, M S, McCarthy, R J, et al. The incidence of venous air embolism during total hip arthroplasty. J Clin Anesth. 1988; 1(1):25–30.

Lew, T W, Tay, D H, Thomas, E. Venous air embolism during cesarean section: More common than previously thought. Anesth Analg. 1993; 77(3):448–52.

Nishiyama, T, Hanaoka, K. Gas embolism during hysteroscopy. Can J Anaesth. 1999; 46(4):379–81.

Chang, J L, Skolnick, K, Bedger, R, Schramm, V, Bleyaert, A L. Postoperative venous air embolism after removal of neck drains. Arch Otolaryngol. 1981; 107(8):494–6.

Ledowski, T, Kiese, F, Jeglin, S, Scholz, J. Possible air embolism during eye surgery. Anesth Analg. 2005; 100(6):1651–2.

Suzuki, K, Ueda, M, Abe, A, et al. Paradoxical cerebral air embolism occurred with postural change during rehabilitation, in a patient with ipsilateral internal carotid artery occlusion. Intern Med. 2012; 51(9):1107–9.

Timpa, J G, O’Meara, C, McIlwain, R B, Dabal, R J, Alten, J A. Massive systemic air embolism during extracorporeal membrane oxygenation support of a neonate with acute respiratory distress syndrome after cardiac surgery. J Extra Corpor Technol. 2011; 43(2):86–8.

Ueda, K, Kaneda, Y, Sudo, M, et al. Cerebral air embolism during imaging of a sentinel lymphatic drainage in the respiratory tract. Ann Thorac Surg. 2006; 81(2):721–3.

Singh, A, Ramanakumar, A, Hannan, J. Simultaneous left ventricular and cerebral artery air embolism after computed tomographic-guided transthoracic needle biopsy of the lung. Tex Heart Inst J. 2011; 38(4):424–6.

Le Guen, M, Trebbia, G, Sage, E, Cerf, C, Fischler, M. Intraoperative cerebral air embolism during lung transplantation: Treatment with early hyperbaric oxygen therapy. J Cardiothorac Vasc Anesth. 2012; 26(6):1077–9.

Frasco, P E, Caswell, R E, Novicki, D. Venous air embolism during transurethral resection of the prostate. Anesth Analg. 2004; 99(6):1864–6.

Tsou, M Y, Teng, Y H, Chow, L H, Ho, C M, Tsai, S K. Fatal gas embolism during transurethral incision of the bladder neck under spinal anesthesia. Anesth Analg. 2003; 97(6):1833–4.

Nayagam, J, Ho, K M, Liang, J. Fatal systemic air embolism during endoscopic retrograde cholangio-pancreatography. Anaesth Intensive Care. 2004; 32(2):260–4.

Akhtar, N, Jafri, W, Mozaffar, T. Cerebral artery air embolism following an esophagogastroscopy: A case report. Neurology. 2001; 56(1):136–7.

Katzgraber, F, Glenewinkel, F, Rittner, C, Beule, J. Fatal air embolism resulting from gastroscopy. Lancet. 1995; 346:1714–15.

Lowdon, J D, Tidmore, T L Jr. Fatal air embolism after gastrointestinal endoscopy. Anesthesiology. 1988; 69(4):622–3.

Zini, A, Carpeggiani, P, Pinelli, G, Nichelli, P. Brain air embolism secondary to atrial-esophageal fistula. Arch Neurol. 2012; 69(6):785.

Williams, T L, Parikh, D R, Hopkin, J R, et al. Teaching neuroimages: Cerebral air embolism secondary to atrial-esophageal fistula. Neurology. 2009; 72(12):e54–55.

Hertz, J A, Schinco, M A, Frykberg, E R. Extensive pneumocranium. J Trauma. 2002; 52(1):188.

Laskey, A L, Dyer, C, Tobias, J D. Venous air embolism during home infusion therapy. Pediatrics. 2002; 109(1):1–3.

Grace, D M. Air embolism with neurologic complications: A potential hazard of central venous catheters. Can J Surg. 1977; 20(1):51–3.

Seeburger, J, Borger, M A, Merk, D R, et al. Massive cerebral air embolism after bronchoscopy and central line manipulation. Asian Cardiovasc Thorac Ann. 2009; 17(1):67–9.

Clark, D K, Plaizier, E. Devastating cerebral air embolism after central line removal. J Neurosci Nurs. 2011; 43(4):193–6.

Yee, E S, Verrier, E D, Thomas, A N. Management of air embolism in blunt and penetrating thoracic trauma. J Thorac Cardiovasc Surg. 1983; 85(5):661–8.

Lai, C C, Chuang, C H, Chao, C M, Liu, W L, Hou, C C. Pulmonary artery air embolism after blunt trauma. Resuscitation. 2011; 82(4):369–70.

Hwang, S L, Lieu, A S, Lin, C L, et al. Massive cerebral air embolism after cardiopulmonary resuscitation. J Clin Neurosci. 2005; 12(4):468–9.

Arena, V, Capelli, A. Venous air embolism after cardiopulmonary resuscitation: The first case with histological confirmation. Cardiovasc Pathol. 2010; 19(2):43–4.

Schwerzmann, M, Seiler, C. Recreational scuba diving, patent foramen ovale and their associated risks. Swiss Med Wkly. 2001; 131(25–26): 365–74.

Spira, A. Diving and marine medicine review part II: Diving diseases. J Travel Med. 1999; 6(3):180–98.

Kapoor, T, Gutierrez, G. Air embolism as a cause of the systemic inflammatory response syndrome: A case report. Crit Care. 2003; 7(5):98–100.

Alvaran, S B, Toung, J K, Graff, T E, Benson, D W. Venous air embolism: Comparative merits of external cardiac massage, intracardiac aspiration, and left lateral decubitus position. Anesth Analg. 1978; 57(2):166–70.

Toung, T J, Rossberg, M I, Hutchins, G M. Volume of air in a lethal venous air embolism. Anesthesiology. 2001; 94(2):360–1.

Vann, R D, Butler, F K, Mitchell, S J, Moon, R E. Decompression illness. Lancet. 2011; 377(9760):153–64.

Raju, G S, Bendixen, B H, Khan, J, Summers, R W. Cerebrovascular accident during endoscopy: Consider cerebral air embolism, a rapidly reversible event with hyperbaric oxygen therapy. Gastrointest Endosc. 1998; 47(1):70–3.

Gursoy, S, Duger, C, Kaygusuz, K, et al. Cerebral arterial air embolism associated with mechanical ventilation and deep tracheal aspiration. Case Rep Pulmonol. 2012; 2012:1–2.

Heckmann, J G, Lang, C J, Kindler, K, et al. Neurologic manifestations of cerebral air embolism as a complication of central venous catheterization. Crit Care Med. 2000; 28(5):1621–5.

Ho, A M, Ling, E. Systemic air embolism after lung trauma. Anesthesiology. 1999; 90(2):564–75.

de Blauw, M H. An unusual complication of a central venous catheter placement. Neth J Med. 2012; 70(1):40–4.

Kuwahara, T, Takahashi, A, Takahashi, Y, et al. Clinical characteristics of massive air embolism complicating left atrial ablation of atrial fibrillation: Lessons from five cases. Europace. 2012; 14(2):204–8.

Fitchet, A, Fitzpatrick, A P. Central venous air embolism causing pulmonary oedema mimicking left ventricular failure. BMJ. 1998; 316(7131):604–6.

Valentino, R, Hilbert, G, Vargas, F, Gruson, D. Computed tomographic scan of massive cerebral air embolism. Lancet. 2003; 361(9372):1848.

Herber, N, Salvolin, L, Salvolini, U. Changes in CT evidence of massive cerebral air embolism. Eur J Radiol Extra. 2004; 51:9–10.

Suzuki, T, Ando, T, Usami, A, et al. Cerebral air embolism as a complication of peptic ulcer in the gastric tube: case report. BMC Gastroenterol. 2011; 11:139–41.

Griese, H, Seifert, D, Koerfer, R. Cortical infarction following cardiosurgical procedures: Air embolism as a probable cause. Eur Neurol. 2009; 61(6):343–9.

Gao, G K, Wu, D, Yang, Y, et al. Cerebral magnetic resonance imaging of compressed air divers in diving accidents. Undersea Hyperb Med. 2009; 36(1):33–41.

Rodriguez, R A, Rubens, F D, Wozny, D, Nathan, H J Cerebral emboli detected by transcranial Doppler during cardiopulmonary bypass are not correlated with postoperative cognitive deficits. Stroke. 2010; 41(10):2229–35.

Furuya, H, Okumura, F. Detection of paradoxical air embolism by transesophageal echocardiography. Anesthesiology. 1984; 60(4):374–7.

Romero, J R, Frey, J L, Schwamm, L H, et al. Cerebral ischemic events associated with ‘bubble study’ for identification of right to left shunts. Stroke. 2009; 40(7):2343–8.

Tsivgoulis, G, Stamboulis, E, Sharma, V K, et al. Safety of transcranial Doppler ‘bubble study’ for identification of right to left shunts: An international multicentre study. J Neurol Neurosurg Psychiatry. 2011; 82(11):1206–8.

Orebaugh, S L. Venous air embolism: Clinical and experimental considerations. Crit Care Med. 1992; 20(8):1169–77.

Mehlhorn, U, Burke, E J, Butler, B D, et al. Body position does not affect the hemodynamic response to venous air embolism in dogs. Anesth Analg. 1994; 79(4):734–9.

Bowdle, T A, Artru, A A. Treatment of air embolism with a special pulmonary artery catheter introducer sheath in sitting dogs. Anesthesiology. 1988; 68(1):107–10.

Bedford, R F, Marshall, W K, Butler, A, Welsh, J E. Cardiac catheters for diagnosis and treatment of venous air embolism: A prospective study in man. J Neurosurg. 1981; 55(4):610–14.

Kol, S, Ammar, R, Weisz, G, Melamed, Y. Hyperbaric oxygenation for arterial air embolism during cardiopulmonary bypass. Ann Thorac Surg. 1993; 55(2):401–3.

Sahni, T, Jain, M. Hyperbaric oxygen therapy: Research indications and emerging role in neurological illnesses. Apollo Med. 2005; 2(1):16–20.

Mortensen, C R. Hyperbaric oxygen therapy. Curr Anaesth Crit Care. 2008; 19:333–7.

Murphy, B P, Harford, F J, Cramer, F S. Cerebral air embolism resulting from invasive medical procedures. Treatment with hyperbaric oxygen. Ann Surg. 1985; 201(2):242–5.

Newcomb, A, Frawley, G, Fock, A, Bennett, M, d’Udekem, Y. Hyperbaric oxygenation in the management of cerebral arterial gas embolism during cavopulmonary connection surgery. J Cardiothorac Vasc Anesth. 2008; 22(4):576–80.

Blanc, P, Boussuges, A, Henriette, K, Sainty, J M, Deleflie, M. Iatrogenic cerebral air embolism: Importance of an early hyperbaric oxygenation. Intensive Care Med. 2002; 28(5):559–63.

Dutka, A J, Mink, R, McDermott, J, Clark, J B, Hallenbeck, J M. Effect of lidocaine on somatosensory evoked response and cerebral blood flow after canine cerebral air embolism. Stroke. 1992; 23(10):1515–20.

McDermott, J J, Dutka, A J, Evans, D E, Flynn, E T. Treatment of experimental cerebral air embolism with lidocaine and hyperbaric oxygen. Undersea Biomed Res. 1990; 17(6):525–34.

Mitchell, S J, Merry, A F, Frampton, C, et al. Cerebral protection by lidocaine during cardiac operations: A follow-up study. Ann Thorac Surg. 2009; 87(3):820–5.

Ballham, A, Allen, M J. Air embolism in a sports diver. Br J Sports Med. 1983; 17(1):7–9.

Dutka, A J, Mink, R B, Pearson, R R, Hallenbeck, J M. Effects of treatment with dexamethasone on recovery from experimental cerebral arterial gas embolism. Undersea Biomed Res. 1992; 19(2):131–41.

Ryu, K H, Hindman, B J, Reasoner, D K, Dexter, F. Heparin reduces neurological impairment after cerebral arterial air embolism in the rabbit. Stroke. 1996; 27(2):303–9.

Vane, J R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971; 231:232–5.

Evangelista, V, Manarini, S, Di Santo, A, et al. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res. 1998; 593–5.

Bjornsson, T D, Schneider, D E, Berger, H. Aspirin aetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharmacol Exp Ther. 1989; 250:154–61.

De Schryver, E L L M, van Gijn, J, Kappelle, L J, Koudstaal, P J, Algra, A. Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol. 2005;252:1316–21.

Kovich, O, Clark, C O. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol. 2003; 48:233–7.

Sibon, I, Orgogozo, J-M. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology. 2004; 62:1187–9.

Maulaz, A B, Bezerra, D C, Michel, P, Bogousslavsky, J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005; 62:1217–20.

Broderick, J P, Bonomo, J B, Kissela, B M, et al. Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence. Stroke. 2011; 42:2509–14.

Watanabe, H, Morimoto, T, Natsuaki, M, et al. Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: Observations from the CREDO-Kyoto Registry Cohort-2. PLoS One. 2015; 10(4):e0124314.

Rossini, R, Musumeci, G, Capodanno, D, et al. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry. Thromb Haemost. 2015; 113(2):272–82.

Burger, W, Chemnitius, J M, Kneissl, G D, Rücker, G. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks ater its perioperative withdrawal versus bleed risks with its continuation – review and meta-analysis. J Int Med. 2005; 257:399–414.

García Rodríguez, L A, Soriano, L C, Hill, C, Johansson, S. Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology. 2011; 76:740–6.

Weimar, C, Cotton, D, Sha, N, et al. Discontinuation of antiplatelet study medication and risk of recurrent stroke and cardiovascular events: results from the PRoFESS study. Cerebrovasc Dis. 2013; 35:538–43.

Lee, J, Kim, J K, Kim, J H, et al. Recovery time of platelet function after aspirin withdrawal. Curr Ther Res Clin Exp. 2014; 76:26–31.

Le Manach, Y, Kahn, D, Bachelot-Loza, C, et al. Impact of aspirin and clopidogrel interruption on platelet function in patients undergoing major vascular surgery. PLoS One. 2014; 9(8):e104491.

Aguejouf, O, Belougne-Malfatti, E, Doutremepuich, F, Belon, P, Doutremepuich, C. Thromboembolic complications several days after a single-dose administration of aspirin. Thromb Res. 1998; 89(3):123–7.

Doutremepuich, C, Aguejouf, O, Eizayaga, F X, Desplat, V. Reverse effect of aspirin: is the prothrombotic effect after aspirin discontinuation mediated by cyclooxygenase 2 inhibition? Pathophysiol Haemost Thromb. 2007; 36:40–4.

Aguejouf, O, Eizayaga, F, Desplat, V, Belon, P, Doutremepuich, C. Prothrombotic and hemorrhagic effects of aspirin. Clin Appl Thromb Hemost. 2009; 15(5):523–8.

Vial, J H, McLeod, L J, Roberts, M S. Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal. Adv Prostatglandin Thromboxane Leukot Res. 1991; 21:157–60.

Moussa, S A, Forsythe, M S, Bozarth, J M, Reilly, T M. Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1. Cardiology. 1993; 83:367–73.

Armstrong, M J, Gronseth, G, Anderson, D C, et al. Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: Report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2013; 80:2065–9.

Mantz, J, Samama, C M, Tubach, F, et al. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: The multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth. 2011; 107(6):899–910.

Dorsam, R T, Kunapuli, S P. Central role of the P2Y12 receptor in platelet activation. J Clin Invest. 2004; 113(3):340–5.

CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996; 348(9038):1329–39.

Diehl, P, Halscheid, C, Olivier, C, et al. Discontinuation of long term clopidogrel therapy induces platelet rebound hyperaggregability between 2 and 6 weeks post cessation. Clin Res Cardiol. 2011; 100:765–71.

Sambu, N, Warner, T, Curzen, N. Clopidogrel withdrawal: is there a “rebound” phenomenon? Thromb Haemost. 2011; 105:211–20.

Collet, J-P, Montalescot, G, Steg, P G, et al. Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial. Arch Cardiovasc Dis. 2009; 102:485–96.

Geraghty, O C, Paul, N L M, Chandratheva, A, Rothwell, P M. Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke. Neurology. 2010; 74:1891–6.

Ford, I, Scott, N W, Herd, V, et al. A randomized controlled trial of platelet activity before and after cessation of clopidogrel therapy in patients with stable cardiovascular disease. J Am Coll Cardiol. 2014; 63:233–9.

Rossen, J D, Chalouhi, N, Wassef, S N, et al. Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques. J Neurosurg. 2012; 117:929–33.

Fiedler, A K, Mehilli, J, Kufner, S, et al. Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation. Thromb Haemost. 2014; 111:1041–9.

Mauri, L, Kereiakes, D J, Yeh, R W, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;Nov 16 (Epub ahead of print).

Vongpatanasin, W, Hillis, L D, Lange, R A. Prosthetic heart valves. N Engl J Med. 1996; 335:407–16.

The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. Eur Heart J. 2010; 31:2369–429.

Douketis, J D, Berger, P B, Dunn, A S, et al. The perioperative management of antithrombotic therapy. American College of Chest Physicians evidence-based clinicial practice guidelines (8th edition). Chest. 2008; 133:299–339S.

Di Biase, L, Burkhardt, J D, Santangeli, P, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management. Results from the role of coumadin in preventing thromboembolism in atrial fibrillation patients undergoing catheter ablation (COMPARE) randomized trial. Circulation. 2014; 129:2638–44.

Fang, M C, Go, A S, Chang, Y, Borowsky, L H, et al. Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010; 3:624–31.

Tulner, L R, Van Campen, J P C M, Kuper, I M J A, et al. Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation. A prospective, descriptive study. Drugs Aging. 2010; 27(1):39–50.

Blacker, D J, Wijdicks, E F M, McClelland, R L. Stroke risk in anticoagulated patients with atrial fibrillation. Neurology. 2003; 61:964–8.

Raunsø, J, Selmer, C, Olesen, J B, et al. Increased short-term riks of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. Eur Heart J. 2012; 33(15):1886–92.

Di Biase, L, Gaita, F, Toso, E, et al. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study. Heart Rhythm. 2014; 11(5):791–8.

Garcia, D A, Regan, S, Henault, L E, et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med. 2008; 168(1):63–9.

Cundiff, D K. Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism. Medscape J Med. 2008; 10(11):258.

Genewein, U, Haeberli, A, Straub, P W, Beer, J H. Rebound after cessation of oral anticoagulant therapy: The biochemical evidence. Br J Haematol. 1996;92:479–85.

Reddy, V Y, Sievert, H, Halperin, J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: A randomized clinical trial. JAMA. 2014; 312(19):1988–98.

Bai, R, Horton, R P, Di Biase, L, et al. Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the Watchman device: A single center experience. J Cardiovasc Electrophysiol. 2012; 23(5):455–61.

Chatterjee, S, Sardar, P, Giri, J S, Ghosh, J, Mukherjee, D. Treatment discontinuations with new oral agents for long-term anticoagulation: Insights from a meta-analysis of 18 randomized trials including 101,801 patients. Mayo Clin Proc. 2014; 89(7):896–907.

Zalesak, M, Siu, K, Francis, K, et al. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin. Circ Cardiovasc Qual Outcomes. 2013; 6(5):567–74.

Nascimento, T, Birnie, D H, Healey, J S, et al. Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey. Can J Cardiol. 2014; 30(2):231–6.

Watanabe, M, Siddiqui, F M, Qureshi, A I. Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment. Neurocrit Care. 2012; 16:203–9.

Patel, M R, Hellkamp, A S, Lokhnygina, Y, et al. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: Analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). J Am Coll Cardiol. 2013; 61(6):651–8.

Reynolds, M R. Discontinuation of rivaroxaban: Filling in the gaps. J Am Coll Cardiol. 2013;61(6):659–60.

Granger, C B, Alexander, J H, McMurray, J J, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011; 365(11):981–92.

Granger, C B, Lopes, R D, Hanna, M, et al. Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Am Heart J. 2015; 169(1):25–30.

Connolly, S J, Ezekowitz, M D, Yusuf, S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361(12):1139–51.

Giugliano, R P, Ruff, C T, Braunwald, E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013; 369(22):2093–104.

Davignon, J, Leiter, L A. Ongoing clinical trials of the pleiotropic effects of statins. Vasc Health Risk Manag. 2005; 1(1):29–40.

Amarenco, P, Bogousslavsky, J, Callahan, A, et al. High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) investigators. N Eng J Med. 2006; 355:549–59.

Colvicchi, F, Bassi, A Santini, M, Caltagirone, C. Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke. 2007; 38:2652–7.

Blanco, M, Nombela, F, Castellanos, M, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology. 2007; 69:904–10.

Fuentes, B, Martínez-Sánchez, P, Díez-Tejedor, E. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Cerebrovasc Dis. 2009; 27(1):126–33.

Endres, M. Statins and stroke. J Cereb Blood Flow Metab. 2005; 25(9):1093–110.

Li, J-J, Li, Y-S, Chu, J-M, et al. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia. Clinica Chimica Acta. 2006; 366:269–73.

Rosengarten, B, Auch, D, Kaps, M. Effects of initiation and acute withdrawal of statins on the neurovascular coupling mechanism in healthy, normocholesterolemic humans. Stroke. 2007; 38:3193–7.

Dowlatshahi, D, Demchuk, A M, Fang, J, et al. Association of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhage. Stroke. 2012; 43:1518–23.

Robinson, T G, Potter, J F, Ford, G A, et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): A prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 2010; 9(8):767–75.

Bath, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): A partial-factorial randomised controlled trial. Lancet. 2014; 22 October: Epub ahead of print.

Baird, T A, Parsons, M W, Phan, T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003; 34:2208–14.

Rosso, C, Corvol, J C, Pires, C, et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke: Results from the randomized INSULINFARCT trial. Stroke. 2012; 43(9):2343–9.

Book contents

Section III - Iatrogenic ischemic strokes: other causes

Access options

References

References

References

References

References